Discovering and Developing PI3 Kinase Inhibitors for Cancer: Rapid Progress Through Academic-Biotech-Pharma Interactions
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-11-0739
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2011
Authors
Publisher
American Association for Cancer Research (AACR)